Nukedit Login.ASP Cross-Site Scripting Vulnerability
BID:25081
Info
Nukedit Login.ASP Cross-Site Scripting Vulnerability
| Bugtraq ID: | 25081 |
| Class: | Input Validation Error |
| CVE: |
CVE-2007-4052 |
| Remote: | Yes |
| Local: | No |
| Published: | Jul 26 2007 12:00AM |
| Updated: | May 07 2015 05:36PM |
| Credit: | d3hydr8 is credited with the discovery of this vulnerability. |
| Vulnerable: |
nukedit nukedit 4.9.7 nukedit nukedit 4.9.6 nukedit nukedit 4.9.5 nukedit nukedit 4.9.7b |
| Not Vulnerable: | |
Discussion
Nukedit Login.ASP Cross-Site Scripting Vulnerability
Nukedit is prone to a cross-site scripting vulnerability because the application fails to properly sanitize user-supplied input.
An attacker may leverage this issue to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This may help the attacker steal cookie-based authentication credentials and launch other attacks.
Nukedit is prone to a cross-site scripting vulnerability because the application fails to properly sanitize user-supplied input.
An attacker may leverage this issue to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This may help the attacker steal cookie-based authentication credentials and launch other attacks.
Exploit / POC
Nukedit Login.ASP Cross-Site Scripting Vulnerability
An attacker can exploit this issue by enticing an unsuspecting user to follow a malicious URI.
An example URI has been provided:
An attacker can exploit this issue by enticing an unsuspecting user to follow a malicious URI.
An example URI has been provided:
Solution / Fix
Nukedit Login.ASP Cross-Site Scripting Vulnerability
Solution:
Currently we are not aware of any vendor-supplied patches for this issue. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].
Solution:
Currently we are not aware of any vendor-supplied patches for this issue. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].